Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.1
Stockholders' Equity (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Stockholders' Equity (Details) [Line Items]      
Authorized to issue and sale of stock 185,000,000    
Common stock, shares authorized 180,000,000    
Common stock, par value (in Dollars per share) $ 0.001   $ 0.001
Preferred stock, shares authorized 5,000,000   5,000,000
Preferred stock, par value (in Dollars per share) $ 0.001   $ 0.001
Preferred stock, outstanding 0 0  
Options to purchase common stock 30,208    
Cash proceeds of exercised, stock options (in Dollars) $ 958,847  
Stock options term 10 years    
Awardee over a period 4 years    
Warrant [Member]      
Stockholders' Equity (Details) [Line Items]      
Warrants to purchase of common stock expired 200,000    
Stock Option [Member]      
Stockholders' Equity (Details) [Line Items]      
Options to purchase common stock 400,000    
Cash proceeds of exercised, stock options (in Dollars) $ 0.43    
Grant date fair value (in Dollars per share) $ 100,000    
Stock Option [Member] | 2011 plan [Member]      
Stockholders' Equity (Details) [Line Items]      
Remaining options to be issued 2,900,000